Efficacy of a Mass Hepatitis B Vaccination Program in Taiwan: Studies on 3464 Infants of Hepatitis B Surface Antigen—Carrier Mothers

JAMA: The Journal of the American Medical Association

Volumn 260, Issue 15, 1988, Pages 2231-2235

  Hsu, Hsu Mei ^a   Chen, Ding Shinn ^a   Chuang, Cheng Hua ^a   Li, Joseph Chih Feng ^a   Jwo, Min ^a   Lee, Chin Chang ^a   Li, Hsing Chi ^a   Cheng, Shih Hsiung ^a   Wang, Yue Fen ^a   Wang, Chinying Chen ^a   Li, Kwang Juei ^a   Shih, Chun Jen ^a   Sung, Juei Low ^a  

^a INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

DRUG EFFICACY; HEALTH PROGRAM; HEPATITIS B; HUMAN; HUMAN CELL; INFANT; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; SEROLOGY; TAIWAN; VACCINATION;

CARRIER STATE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMAN; IMMUNIZATION SCHEDULE; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; INFANT; INFANT, NEWBORN; MALE; TAIWAN; VIRAL HEPATITIS VACCINES;

EID: 0023784863     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1988.03410150079034     Document Type: Article

References (24)

1. Chen DS, Sung JL: Hepatitis B virus infection and chronic liver diseases in Taiwan. Acta Hepato-Gastroenterol 1978;25:423-430.
2. Sung JL, Chen DS, Lai MY, et al.: Epidemiological study on hepatitis B virus infection in Taiwan. Chin J Gastroenterol 1984;1:1-9.
3. Health Statistics: Vital Statistics of Republic of China. Taipei, Taiwan, Dept of Health, Executive Yuan, 1984, vol 2, pp 44-45,100-101.
4. Lin TM, Tsu WT, Chen CJ: Mortality of hepatoma and cirrhosis of liver in Taiwan. Br J Cancer 1986;54:969-976.
5. Sung JL, Chen DS: Hepatitis B surface antigen and antibody in liver disease in Taiwan, in Lee SK, Sinniah R, Tan LKA, et al. (eds): Proceedings of the Fifth Asian-Pacific Congress of Gastroenterology. Singapore, Gastroenterological Society of Singapore, 1976, pp 265-269.
6. Beasley RP, Hwang LY, Lin CC, et al.: Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22707 men in Taiwan. Lancet 1981;2:1129-1133.
7. Chen DS: Hepatitis B virus infection, its sequelae, and prevention in Taiwan, in Okuda K, Ishak KG (eds): Neoplasms of the Liver. Tokyo, Springer-Verlag, 1987, pp 71-80.
8. Stevens CE, Beasley RP, Tsui J, et al.: Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292:771-774.
9. Stevens CE, Neurath RA, Beasley RP, et al.: HBeAg and anti-HBe detection by radioimmunoassay: Correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol 1979;3:237-241.
10. Ko TM, Lin KH, Ho MM, et al.: Perinatal transmission of hepatitis B in the Tao Yuan area. J Formosan Med Assoc 1986;85:341-351.
11. Sung JL, Chen DS: Maternal transmission of hepatitis B surface antigen in patients with hepatocellular carcinoma in Taiwan. Scand J Gastroenterol 1980;15:321-324.
12. Beasley RP, Hwang LY, Lee GCY, et al.: Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2:1099-1102.
13. Lo KJ, Tsai YT, Lee SD, et al.: Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J Infect Dis 1985;152:817-822.
14. Chen DS, Hsu NHM, Sung JL, et al.: A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen—carrier mothers. JAMA 1987;257:2597-2603.
15. Fleiss JL: Assessing significance in a fourfold table, in Fleiss JL (ed): Statistical Methods for Rates and Proportions. New York, John Wiley & Sons Inc, 1980, pp 19-32.
16. Beasley RP, Hwang LY, Lin CC, et al.: Incidence of hepatitis B virus infection in preschool children in Taiwan. J Infect Dis 1982;146:198-204.
17. McMahon BJ, Alward WLM, Hall DB, et al.: Acute hepatitis B virus infection: Relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985;151:599-603.
18. Stevens CE, Taylor PE, Tong MJ, et al.: Yeastrecombinant hepatitis B vaccine: Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987;257: 2612-2616.
19. Xu ZY, Liu CB, Francis DP, et al.: Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: Preliminary report of a randomized, double-blind placebo-controlled and comparative trial. Pediatrics 1985;76:713-718.
20. Stevens CE, Toy PT, Tong MJ, et al.: Perinatal hepatitis B virus transmission in the United States: Prevention by passive-active immunization. JAMA 1985;253:1740-1745.
21. Chung WK, Yoo JY, Sun HS, et al.: Prevention of perinatal transmission of hepatitis B virus: A comparison between the efficacy of passive and passive-active immunization in Korea. J Infect Dis 1985;151:280-286.
22. Sinatra SR, Shah P, Weissman JY, et al.: Perinatal transmitted acute icteric hepatitis B in infants born to hepatitis B surface antigen—positive and anti-hepatitis B e—positive carrier mothers. Pediatrics 1982;70:557-559.
23. Chang MH, Lee CY, Chen DS, et al.: Fulminant hepatitis in children in Taiwan: The important role of hepatitis B virus. J Pediatr 1987;111:34-39.
24. Chen DS, Sung JL, Lai MY, et al.: Inadequacy of immunoglobulin M hepatitis B core antibody in detecting acute hepatitis B virus infection in infants of HBsAg carrier mothers. J Med Virol 1985;16: 309-314.